MedTrace Logo

Shoulder Proprioception Following Open and Arthroscopic Instability Repair

NCT00889109 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2009-04-28

No results posted yet for this study

Summary

Shoulder dislocations are common and may result in functionally disabling instability. Disruption of the shoulder capsuloligamentous complex during shoulder dislocation is related to poor proprioceptive and stabilizing capabilities of the joint. It has been demonstrated that surgical restoration of the normal glenohumeral capsular tensioning improves the proprioceptive capability of the shoulder and plays an important roll in restoring shoulder stability.

Several studies compared the proprioceptive capabilities of the shoulder between different surgical procedures, however only few have used the "dynamic unrestricted 3-dimensional arm movement model" that has been shown to be more appropriate for assessment of glenohumeral proprioception. To our knowledge, no previous study has compared proprioception measures of the glenohumeral joint following arthroscopic versus open repair for anterior shoulder instability, using the 3-dimensional unrestricted arm movement model.

Conditions

  • Shoulder Proprioception
  • Open Capsular Shift
  • Arthroscopic Bankart Repair
  • Unrestricted Arm Movement

Interventions

OTHER

Three dimensional unrestricted arm movements

The subjects will carry out three dimensional unrestricted arm movements. The subjects' movements will be recorded by optoelectronic infrared cameras and software. Assessment of smoothness parameters of subjects' movements will allow discriminating between subjects with intact or impaired proprioception.

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Dario Liebermann, PhD. · Department of Physical Therapy, Sackler Faculty of Medicine, Tel Aviv University, Israel

  • Moshe Peri (Pritsch), M.D · The Shoulder Surgery Unit, Sheba Medical Center, Tel Aviv University, Israel

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2009-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00889109 on ClinicalTrials.gov